Showing 361-370 of 856 results for "".
- New Solution to Alleviate Challenges from Denied Insurance Claims Unveiledhttps://modernaesthetics.com/news/new-solution-to-alleviate-challenges-from-denied-insurance-claims-unveiled-1/2473757/A new solution to alleviate the challenges posed by insurance claim denials and make it easier for providers to salvage denied claims and increase their reimbursement was on display at the 2025 American Academy of Dermatology (AAD) Annual Meeting in Orlando, Florida, as Nextech previewed the late
- 2025 AAD Meeting: The Power of Social Media in Dermatology to Educate, Engage, and Inspirehttps://modernaesthetics.com/news/2025-aad-meeting-the-power-of-social-media-in-dermatology-to-educate-engage-and-inspire/2473749/Combatting misinformation that is spread on social media was one of the session topics at the 2025 American Academy of Dermatology Annual Meeting in Orlando, Florida on Friday. Among the speakers was Lindsey Zubritsky, MD, FAAD, or the dermguru, as she’s known on social media. Dr. Zubritsky
- Dr. Kay Talks Safeguarding Your Skin from Smoke Damage, Pollution Amid Devastating Los Angeles Wildfireshttps://modernaesthetics.com/news/dr-kay-talks-safeguarding-your-skin-from-smoke-damage-pollution-amid-devastating-los-angeles-wildfires/2473728/It’s been a somber week for residents across California as wildfires left behind mass devastation across multiple neighborhoods in Los Angeles. As firefighters battle to get the wildfires under control, some residents of evacuated areas are beginning to return to what they once called home.
- Recent Wall Street Journal Article “Belittles” Efforts of Dermatologists, Dr. Doris Dayhttps://modernaesthetics.com/news/recent-wall-street-journal-article-belittles-efforts-of-dermatologists-dr-doris-day/2473719/Modern Aesthetics Editorial Board member Doris Day, MD, FAAD, didn’t hold back when speaking out against a recent Wall Street Journal article portraying dermatology as a cushiony specialty and citing that as a reason it is gaining increasing traction from me
- DefenAge Skincare Launches New Packaging for 150K Hair Follicle Serumhttps://modernaesthetics.com/news/defenage-skincare-launches-new-packaging-for-150k-hair-follicle-serum/2473710/DefenAge announced a new, revolutionary hair serum application system on Tuesday. The new dispenser integrates cutting-edge functionality with sustainability, reinforcing DenfeAge’s ongoing commitment to innovation in skincare technology, a press release said. The dispenser
- Study: PLLA-SCA Induces Adipogenesis and Volumization of the Hip Dellhttps://modernaesthetics.com/news/study-plla-sca-induces-adipogenesis-and-volumization-of-the-hip-dell/2473709/Injecting poly-l-lactic acid (PLLA-SCA) is a safe and effective method for durable volumization and aesthetic improvement of the hip dell, and may promote adipogenesis and elastogenesis, according to a new study published in Dermatologic Surgery. &ldq
- Porous Dermal Fillers Show Promise for Diabetic Wound Treatment, Research Findshttps://modernaesthetics.com/news/porous-dermal-fillers-show-promise-for-diabetic-wound-treatment-research-finds/2473706/A groundbreaking study published in ACS Nano introduced an innovative approach for using specialized porous dermal fillers that accelerate tissue healing and regeneration. The injectable granular filler was developed by researchers at the Terasaki Institute for Biomedical Innovation (TIBI) and co
- DefenAge Skincare Launches 12-Factor Revitalizing Lip Enhancerhttps://modernaesthetics.com/news/defenage-skincare-launches-12-factor-revitalizing-lip-enhancer/2473701/DefenAge Skincare introduces a “revolutionary, first-of-its kind” anti-aging serum for fuller, smoother and more youthful lips. The 12-Factor Revitalizing Lip Enhancer is powered by DefenAge’s patented Age-Repair Defensins. The lip serum is designed to rejuvenate lip a
- New Data Demonstrates Long-Term Safety, Efficacy of Galderma’s RelabotulinumtoxinAhttps://modernaesthetics.com/news/new-data-demonstrates-long-term-safety-efficacy-of-galdermas-relabotulinumtoxina/2473698/Galderma presented new phase III data from the READY-4 clinical trial at the American Society for Dermatologic Surgery (ASDS) 2024 Annual Meeting last week. The data demonstrates the long-term safety of RelabotulinumtoxinA (RelfydessTM) for frown lines and crow’s feet after repea
- L&P Aesthetics Earns Distinction for Signature Deep-Plane Facelifthttps://modernaesthetics.com/news/lp-aesthetics-earns-distinction-for-signature-deep-plane-facelift/2473692/L&P Aesthetics, located in Palo Alto and Los Gatos, California, was named Best Facial Plastic Surgery in Silicon Valley Magazine's Best of 2024. The magazine recognized the "refined approach" to the practice’s L&P Signature deep-plane facelift, which lif